Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMB0CXT)

Drug Name
GSK2330811 Drug Info
Indication
Disease Entry ICD 11 Status REF
Crohn disease DD70 Phase 2 [1]
Systemic sclerosis 4A42 Phase 2 [2]
Cross-matching ID
TTD Drug ID
DMB0CXT

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Oncostatin-M (OSM)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ADR58 DMQBCPK Rheumatoid arthritis FA20 Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Oncostatin-M (OSM) TTIVXSE ONCM_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT04151225) Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease (COSMIS). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Therapeutic applications of aptamers. Expert Opin Investig Drugs. 2008 Jan;17(1):43-60.